Skip to content
healthcare.dev

Budesonide Inhalation Suspension

NDC 76282-642, Budesonide, inhalant, from Exelan Pharmaceuticals, Inc..

Product NDC
76282-642
Status
Listed
Labeler
Exelan Pharmaceuticals, Inc.
Dosage form
INHALANT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205710
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-642 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUDESONIDE1 mg/2mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
76282-642-38762820642386 POUCH in 1 CARTON (76282-642-38) / 5 AMPULE in 1 POUCH (76282-642-37) / 2 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d9656442-4587-4867-9a8c-5f5b0402936e

Use it

Look up 76282-642 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-642 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-642. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.